Highlights • Response to corticosteroids in chronic hypersensitivity pneumonia is inconstant. • Rituximab could be considered as a therapeutic alternative. • Rituximab could stabilize or even improve lung function. Abstract Background There are chronic forms of hypersensitivity pneumonitis (cHP) that can progress to pulmonary fibrosis. There is no recommended treatment for patients whose respiratory condition continues to deteriorate in spite of antigen avoidance.